← Back to Directory

Moderna, Inc. (MRNA) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Moderna, Inc. (MRNA).

Download S&P Stocks on Google Play Download S&P Stocks on the App Store

Equity Details

Price & Market Data

Price: $53.39

Daily Change: +$0.51 / 0.96%

Daily Range: $51.25 - $55.41

Market Cap: $21,136,805,888

Daily Volume: 11,248,182

Performance Metrics

1 Week: 14.04%

1 Month: 5.11%

3 Months: 26.85%

6 Months: 117.1%

1 Year: 107.3%

YTD: 80.64%

About Moderna, Inc. (MRNA)

Dive into the latest financial snapshot of Moderna, Inc. (MRNA). With a current trading price of 53.39, the stock has experienced a daily shift of +$0.51 / 0.96%. The company's market capitalization stands impressively at 21,136,805,888. Track its year-to-date performance, which is at 80.64%, alongside its weekly, monthly, and yearly trends.

Company Details

Employees: 4700

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Selected stocks

Merit Medical Systems, Inc. (MMSI)

CleanSpark, Inc. (CLSK)

Edgewell Personal Care Company (EPC)

Woodward, Inc. (WWD)

Brady Corporation (BRC)